Genetically reduced MTHFR activity confers protection against multiple sclerosis

Area of Science:

• Genetics and Molecular Biology
• Neuroimmunology
• Metabolic Disorders

Background:

• Methylenetetrahydrofolate reductase (MTHFR) is crucial for folate metabolism and homocysteine regulation.
• The MTHFR C677T variant impairs enzyme activity, elevating homocysteine levels.
• Previous studies suggest MTHFR variants are linked to neurological diseases, but their role in multiple sclerosis (MS) is unclear.

Purpose of the Study:

• To investigate the association between the MTHFR C677T variant and the risk of developing MS.
• To examine the relationship between the MTHFR C677T variant and MS disease severity.
• To explore the potential biological link between MTHFR function and MS pathogenesis.

Main Methods:

• Meta-analysis of genetic association data for MS risk (43,069 cases) and severity (12,584 cases).
• Analysis of genetic associations with homocysteine levels (1,210 participants).
• Sensitivity analyses were conducted to address potential genetic confounding.

Main Results:

• A statistically significant association was found between the MTHFR C677T variant and reduced MS risk (OR per allele = 0.91, P < 10^-14).
• The variant's effect on MS risk was consistent when scaled to genetically determined homocysteine levels (OR = 0.73, P < 10^-14).
• No significant association was observed between the MTHFR C677T variant and MS severity (P = 0.92).

Conclusions:

• The findings suggest that impaired MTHFR function, indicated by the C677T variant, may offer protection against MS development.
• This supports a novel biological hypothesis connecting folate metabolism and MS risk.
• Further research is warranted to understand the mechanisms and potential therapeutic applications.